{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:52:37Z","timestamp":1789883557857,"version":"4.0.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ijantimicag.2015.04.013","type":"journal-article","created":{"date-parts":[[2015,6,7]],"date-time":"2015-06-07T10:24:22Z","timestamp":1433672662000},"page":"249-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Vancomycin-associated nephrotoxicity: A meta-analysis of administration by continuous versus intermittent infusion"],"prefix":"10.1016","volume":"46","author":[{"given":"Timothy","family":"Hanrahan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Whitehouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lipman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6218-435X","authenticated-orcid":false,"given":"Jason A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2015.04.013_bib0065","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ijantimicag.2015.04.013_bib0070","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.01568-12","article-title":"Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20milligrams per liter","volume":"57","author":"van Hal","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.04.013_bib0075","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1097\/CCM.0000000000000514","article-title":"Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis","volume":"42","author":"Hanrahan","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2015.04.013_bib0080","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2710.2004.00572.x","article-title":"High dose vancomycin for osteomyelitis: continuous vs. intermittent infusion","volume":"29","author":"Vuagnat","year":"2004","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.ijantimicag.2015.04.013_bib0085","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/ALN.0b013e3181a97272","article-title":"Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion","volume":"111","author":"Hutschala","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ijantimicag.2015.04.013_bib0090","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ijantimicag.2009.07.011","article-title":"Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy","volume":"34","author":"Ingram","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2015.04.013_bib0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jac\/dkr442","article-title":"Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis","volume":"67","author":"Cataldo","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.04.013_bib0100","unstructured":"Biostat, Inc. Comprehensive meta-analysis. Englewood, NJ: Biostat, Inc. http:\/\/www.meta-analysis.com [accessed 29.05.15]."},{"key":"10.1016\/j.ijantimicag.2015.04.013_bib0105","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/jac\/35.2.352","article-title":"Comparison of continuous with discontinuous intravenous infusion of vancomycin in severe MRSA infections","volume":"35","author":"Wysocki","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.04.013_bib0110","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1128\/AAC.45.9.2460-2467.2001","article-title":"Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: prospective multicenter randomized study","volume":"45","author":"Wysocki","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.04.013_bib0115","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/000313481307901123","article-title":"Vancomycin intermittent dosing versus continuous infusion for treatment of ventilator-associated pneumonia in trauma patients","volume":"79","author":"Schmelzer","year":"2013","journal-title":"Am Surg"},{"key":"10.1016\/j.ijantimicag.2015.04.013_bib0120","series-title":"The Newcastle\u2013Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2011"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915002010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915002010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T19:53:53Z","timestamp":1652298833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857915002010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0924857915002010"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.04.013","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vancomycin-associated nephrotoxicity: A meta-analysis of administration by continuous versus intermittent infusion","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}